Alnylam Pharmaceuticals
ALNY
#643
Rank
ยฃ29.47 B
Marketcap
ยฃ220.74
Share price
-1.02%
Change (1 day)
3.22%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company